Business Context and Reporting Period
This Form 8-K Current Report was filed by Bausch Health Companies Inc. on July 22, 2025, with the report date reflecting the earliest event reported on that same day. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size from ten to twelve members.
- New Appointments: Michael Goettler and Sandra Leung were appointed as directors, effective July 22, 2025.
- Committee Assignments:
- Mr. Goettler: Talent and Compensation Committee; Science and Technology Committee.
- Ms. Leung: Nominating and Corporate Governance Committee.
- Compensation: Both appointees are eligible for an annual cash retainer and a director equity grant per the Company's non-employee director compensation policy (referenced in the April 2, 2025 Proxy Statement).
Guidance, Outlook, and Risks
The filing contains no management commentary on financial guidance, outlook, risks, contingencies, or unusual items. It notes that a press release announcing these appointments was issued on July 24, 2025, and is furnished as Exhibit 99.1.
Investor Verification Checklist
- Verify the specific compensation amounts for the new directors in the Definitive Proxy Statement on Schedule 14A filed on April 2, 2025.
- Review the attached press release (Exhibit 99.1) for additional biographical details on Mr. Goettler and Ms. Leung.
- Confirm the updated Board composition and committee structures in subsequent corporate governance filings.